How will COVID-19 impact drug funding and reimbursement?
During the ongoing pandemic, the focus on quickly developing COVID-19 vaccines has led countries and global government bodies to make substantial investments...
CRA’s Life Sciences consultants have authored a variety of articles on the effects of the Covid-19 pandemic on life sciences companies, covering issues including the impact on clinical research, physician practices, and vaccine pricing, procurement, and supply. You can read a selection of our thinking below.